Recipharm is a leading global pharmaceutical Contract Development and Manufacturing Organisation (CDMO) headquartered in Sweden, providing drug development, formulation, and commercial manufacturing services across solid, liquid, and sterile dosage forms. With facilities across Europe, India, and North America, the company supports pharmaceutical clients from early-phase development through to large-scale commercial production.